Works matching AU Arlen, Philip M.

Results: 21

Prostate Cancer Immunotherapy: the Role for Sipuleucel-T and Other Immunologic Approaches.

Published in:

Oncology (08909091), 2011, v. 25, n. 3, p. 261

By:

Arlen, Philip M.

Publication type:

Article

The Marshall Article Reviewed.

Published in:

Oncology (08909091), 2005, v. 19, n. 12, p. 1566

By:

Schlom, Jeffrey;
Arlen, Philip M.;
Gulley, James L.

Publication type:

Article

Immunologic and Prognostic Factors Associated with Overall Survival Employing a Poxviral-based PSA Vaccine in Metastatic Castrate-resistant Prostate Cancer.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 5, p. 1, doi. 10.1007/s00262-009-0782-8

By:

Gulley, James L.;
Arlen, Philip M.;
Madan, Ravi A.;
Kwong-Yok Tsang;
Pazdur, Mary P.;
Skarupa, Lisa;
Jones, Jacquin L.;
Poole, Diane J.;
Higgins, Jack P.;
Hodge, James W.;
Cereda, Vittore;
Vergati, Matteo;
Steinberg, Seth M.;
Halabi, Susan;
Jones, Elizabeth;
Chen, Clara;
Parnes, Howard;
Wright, John J.;
Dahut, William L.;
Schlom, Jeffrey

Publication type:

Article

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.

Published in:

Cancer Immunology, Immunotherapy, 2010, v. 59, n. 1, p. 63, doi. 10.1007/s00262-009-0723-6

By:

Cereda, Vittore;
Poole, Diane J.;
Palena, Claudia;
Das, Sudipto;
Bera, Tapan K.;
Remondo, Cinzia;
Gulley, James L.;
Arlen, Philip M.;
Yokokawa, Junko;
Pastan, Ira;
Schlom, Jeffrey;
Tsang, Kwong Y.

Publication type:

Article

Phase I study of a vaccine using recombinant vaccinia virus expressing PSA (rV-PSA) in patients with metastatic androgen-independent prostate cancer.

Published in:

Prostate, 2002, v. 53, n. 2, p. 109, doi. 10.1002/pros.10130

By:

Gulley, James;
Chen, Alice P.;
Dahut, William;
Arlen, Philip M.;
Bastian, Anne;
Steinberg, Seth M.;
Tsang, Kwong;
Panicali, Dennis;
Poole, Diane;
Schlom, Jeffrey;
Michael Hamilton, J.

Publication type:

Article

Cabozantinib plus docetaxel and prednisone in metastatic castration‐resistant prostate cancer.

Published in:

BJU International, 2021, v. 127, n. 4, p. 435, doi. 10.1111/bju.15227

By:

Madan, Ravi A.;
Karzai, Fatima H.;
Al Harthy, Munjid;
Petrylak, Daniel P.;
Kim, Joseph W.;
Arlen, Philip M.;
Rosner, Inger;
Theoret, Marc R.;
Cordes, Lisa;
Bilusic, Marijo;
Peer, Cody J.;
Dawson, Nancy A.;
Couvillon, Anna;
Hankin, Amy;
Williams, Moniquea;
Chun, Guin;
Owens, Helen;
Marte, Jennifer L.;
Lee, Min‐Jung;
Tomita, Yusuke

Publication type:

Article

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas.

Published in:

Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2017.01899

By:

Fantini, Massimo;
David, Justin M.;
Saric, Olga;
Dubeykovskiy, Alexander;
Cui, Yongzhi;
Mavroukakis, Sharon A.;
Bristol, Andrew;
Annunziata, Christina M.;
Tsang, Kwong Y.;
Arlen, Philip M.

Publication type:

Article

A phase 1 dose-escalation study of NEO-102 in patients with refractory colon and pancreatic cancer.

Published in:

2016

By:

Beg, Muhammad;
Azad, Nilofer;
Patel, Sandip;
Torrealba, Jose;
Mavroukakis, Sharon;
Beatson, Melony;
Wang, Xue;
Arlen, Philip;
Morse, Michael;
Beg, Muhammad S;
Azad, Nilofer S;
Patel, Sandip P;
Beatson, Melony A;
Wang, Xue Ping;
Arlen, Philip M;
Morse, Michael A

Publication type:

journal article

Identification of cytotoxic T-lymphocyte epitope(s) and its agonist epitope(s) of a novel target for vaccine therapy (PAGE4).

Published in:

International Journal of Cancer, 2007, v. 121, n. 3, p. 595, doi. 10.1002/ijc.22698

By:

Yokokawa, Junko;
Bera, Tapan K.;
Palena, Claudia;
Cereda, Vittore;
Remondo, Cinzia;
Gulley, James L.;
Arlen, Philip M.;
Pastan, Ira;
Schlom, Jeffrey;
Tsang, Kwong Y.

Publication type:

Article

Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer.

Published in:

Journal of Clinical Pharmacology, 2010, v. 50, n. 6, p. 650, doi. 10.1177/0091270009335001

By:

Dahut, William L.;
Aragon-Ching, Jeanny B.;
Woo, Sukyung;
Tohnya, Tanyifor M.;
Gulley, James L.;
Arlen, Philip M.;
Wright, John J.;
Ventiz, Jurgen;
Figg, William D.

Publication type:

Article

Phase I Study of Oral Lenalidomide in Patients With Refractory Metastatic Cancer.

Published in:

Journal of Clinical Pharmacology, 2009, v. 49, n. 6, p. 650, doi. 10.1177/0091270009335001

By:

Dahut, William L.;
Aragon-Ching, Jeanny B.;
Sukyung Woo;
Tohnya, Tanyifor M.;
Gulley, James L.;
Arlen, Philip M.;
Wright, John J.;
Ventiz, Jurgen;
Figg, William D.

Publication type:

Article

Development of a Serum Biomarker Assay That Differentiates Tumor-Associated MUC5AC (NPC-1C ANTIGEN) from Normal MUC5AC.

Published in:

Journal of Biomedicine & Biotechnology, 2011, p. 1, doi. 10.1155/2011/934757

By:

Luka, Janos;
Arlen, Philip M.;
Bristol, Andrew

Publication type:

Article

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer.

Published in:

Frontiers in Oncology, 2020, v. 11, p. 1, doi. 10.3389/fonc.2020.00805

By:

Zeligs, Kristen P.;
Morelli, Maria Pia;
David, Justin M.;
Neuman, Monica;
Hernandez, Lidia;
Hewitt, Stephen;
Ozaki, Michelle;
Osei-Tutu, Akosua;
Anderson, David;
Andresson, Thorkell;
Das, Sudipto;
Lack, Justin;
Abdelmaksoud, Abdalla;
Fantini, Massimo;
Arlen, Philip M.;
Tsang, Kwong Y.;
Annunziata, Christina M.

Publication type:

Article

Identification of the O-Glycan Epitope Targeted by the Anti-Human Carcinoma Monoclonal Antibody (mAb) NEO-201.

Published in:

Cancers, 2022, v. 14, n. 20, p. 4999, doi. 10.3390/cancers14204999

By:

Tsang, Kwong Y.;
Fantini, Massimo;
Zaki, Anjum;
Mavroukakis, Sharon A.;
Morelli, Maria Pia;
Annunziata, Christina M.;
Arlen, Philip M.

Publication type:

Article

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas.

Published in:

Cancers, 2022, v. 14, n. 13, p. N.PAG, doi. 10.3390/cancers14133037

By:

Tsang, Kwong yok;
Fantini, Massimo;
Mavroukakis, Sharon A.;
Zaki, Anjum;
Annunziata, Christina M.;
Arlen, Philip M.

Publication type:

Article

Rationale, discovery and clinical development of NEO-201.

Published in:

2020

By:

Arlen, Philip M.;
Morelli, Maria Pia

Publication type:

Editorial

Higher Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Metastatic Castration Resistant Prostate Cancer Treated with Anti-Angiogenic Agents.

Published in:

Cancer Investigation, 2009, v. 27, n. 2, p. 221, doi. 10.1080/07357900802208608

By:

Aragon-Ching, Jeanny B.;
Ning, Yang-Min;
Chen, Clara C.;
Latham, Lea;
Guadagnini, Jean-Pierre;
Gulley, James L.;
Arlen, Philip M.;
Wright, John J.;
Parnes, Howard;
Figg, William D.;
Dahut, William L.

Publication type:

Article

Flutamide With or Without PROSTVAC in Non-metastatic Castration Resistant (M0) Prostate Cancer.

Published in:

Oncologist, 2023, v. 28, n. 7, p. 642, doi. 10.1093/oncolo/oyad058

By:

Madan, Ravi A;
Bilusic, Marijo;
Stein, Mark N;
Donahue, Renee N;
Arlen, Philip M;
Karzai, Fatima;
Plimack, Elizabeth;
Wong, Yu-Ning;
Geynisman, Daniel M;
Zibelman, Matthew;
Mayer, Tina;
Strauss, Julius;
Chen, Gang;
Rauckhorst, Myrna;
McMahon, Sheri;
Couvillon, Anna;
Steinberg, Seth;
Figg, William D;
Dahut, William L;
Schlom, Jeffrey

Publication type:

Article

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer.

Published in:

BJU International, 2009, v. 103, n. 12, p. 1636, doi. 10.1111/j.1464-410X.2008.08327.x

By:

Aragon-Ching, Jeanny B.;
Jain, Lokesh;
Gulley, James L.;
Arlen, Philip M.;
Wright, John J.;
Steinberg, Seth M.;
Draper, David;
Venitz, Jürgen;
Jones, Elizabeth;
Chen, Clara C.;
Figg, William D.;
Dahut, William L.

Publication type:

Article

Routine interval computed tomography to detect new soft-tissue disease might be unnecessary in patients with androgen-independent prostate cancer and metastasis only to bone.

Published in:

BJU International, 2007, v. 99, n. 3, p. 525, doi. 10.1111/j.1464-410X.2006.06654.x

By:

Wu, Shenhong L.;
Jones, Elizabeth;
Gulley, James L.;
Arlen, Philip M.;
Chen, Clara C.;
Figg, William D.;
Dahut, William L.

Publication type:

Article

Agonist peptide from a cytotoxic t-lymphocyte epitope of human carcinoembryonic antigen stimulates production of tc1-type cytokines and increases tyrosine phosphorylation more efficiently than cognate peptide.

Published in:

International Journal of Cancer, 2000, v. 85, n. 6, p. 829, doi. 10.1002/(SICI)1097-0215(20000315)85:6<829::AID-IJC16>3.0.CO;2-K

By:

Salazar, Elena;
Zaremba, Sam;
Arlen, Philip M.;
Tsang, Kwong Y.;
Schlom, Jeffrey

Publication type:

Article